scispace - formally typeset
Open AccessJournal ArticleDOI

Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

TLDR
It is demonstrated that CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, VLDL, and, as previously reported, for OxLDL and AcLDL.
About
This article is published in Journal of Lipid Research.The article was published on 1998-04-01 and is currently open access. It has received 374 citations till now. The article focuses on the topics: Foam cell & CD36.

read more

Citations
More filters
Journal ArticleDOI

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

TL;DR: Evidence for a functional role for CD36 in lipoprotein/fatty acid metabolism that was previously underappreciated is provided.
Journal ArticleDOI

Reprogramming of fatty acid metabolism in cancer

TL;DR: This review will examine the mechanisms through which cancer cells rewire their fatty acid metabolism with a focus on four main areas of research, including the role of de novo synthesis and exogenous uptake in the cellular pool of fatty acids.
Journal ArticleDOI

HDL and arteriosclerosis: beyond reverse cholesterol transport.

TL;DR: In this article, the anti-atherogenic properties of HDL have been investigated and the concept of reverse cholesterol transport has been reviewed, which describes both the metabolism and the classic anti-athrogenic function of HDL (Arterioscler. Thromb. Vasc. 20 2001 13).
Journal ArticleDOI

Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake

TL;DR: Recent advances in knowledge of scavenger receptor regulation and signal transduction are focused on, their roles in sterile inflammation and infection, and the potential impact of these pathways in regulating the balance of lipid accumulation and inflammation in the artery wall.
References
More filters
Journal ArticleDOI

The pathogenesis of atherosclerosis: a perspective for the 1990s

TL;DR: The ability to control the expression of genes encoding these molecules and to target specific cell types provides opportunities to develop new diagnostic and therapeutic agents to induce the regression of the lesions and, possibly, to prevent their formation.
Journal ArticleDOI

High density lipoprotein as a protective factor against coronary heart disease: The Framingham study

TL;DR: The major potent lipid risk factor was HDL cholesterol, which had an inverse association with the incidence of coronary heart disease in either men or women and these associations were equally significant even when other lipids and other standard risk factors for coronaryHeart disease were taken into consideration.
Journal ArticleDOI

Role of oxidized low density lipoprotein in atherogenesis.

TL;DR: New ideas suggest new approaches, that in combination with lowering of plasma cholesterol, could lead to the prevention of atherosclerosis and its complications.
Journal ArticleDOI

Binding Site on Macrophages that Mediates Uptake and Degradation of Acetylated Low Density Lipoprotein, Producing Massive Cholesterol Deposition

TL;DR: It is hypothesized that this macrophage uptake mechanism may mediate the degradation of denatured LDL in the body and thus serve as a "backup" mechanism for the previously described receptor-mediated degradation of native LDL that occurs in parenchymal cells.
Journal ArticleDOI

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

TL;DR: The LDL Pathway is a Vehicle for Normal Human PhySIOLOGY and the PATHOGENESIS of ATHEROSCLEROSIS and its implications for normal human physiology and the pathogenesis of AtherOSCLerosis are discussed.
Related Papers (5)